"Genes, bcl-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The B-cell leukemia/lymphoma-1 genes, associated with various neoplasms when overexpressed. Overexpression results from the t(11;14) translocation, which is characteristic of mantle zone-derived B-cell lymphomas. The human c-bcl-1 gene is located at 11q13 on the long arm of chromosome 11.
Descriptor ID |
D019940
|
MeSH Number(s) |
G05.360.340.024.340.375.500.791.148
|
Concept/Terms |
Genes, bcl-1- Genes, bcl-1
- Genes, bcl 1
- Genes, PRAD1
- Gene, PRAD1
- PRAD1 Gene
- PRAD1 Genes
- Genes, Cyclin D1
- bcl-1 Genes
- Gene, bcl-1
- bcl 1 Genes
- bcl-1 Gene
- Cyclin D1 Genes
- Cyclin D1 Gene
- Gene, Cyclin D1
c-bcl-1 Genes- c-bcl-1 Genes
- Gene, c-bcl-1
- Genes, c-bcl-1
- c bcl 1 Genes
- c-bcl-1 Gene
- c-bcl-1 Proto-Oncogenes
- Proto-Oncogene, c-bcl-1
- Proto-Oncogenes, c-bcl-1
- c bcl 1 Proto Oncogenes
- c-bcl-1 Proto-Oncogene
|
Below are MeSH descriptors whose meaning is more general than "Genes, bcl-1".
Below are MeSH descriptors whose meaning is more specific than "Genes, bcl-1".
This graph shows the total number of publications written about "Genes, bcl-1" by people in this website by year, and whether "Genes, bcl-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genes, bcl-1" by people in Profiles.
-
p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor. Cancer Res. 2009 Jan 15; 69(2):440-8.
-
ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. Cancer Res. 2007 May 01; 67(9):4364-72.
-
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood. 2006 Sep 01; 108(5):1744-50.